FDA approves weekly therapy for adult growth hormone deficiency

[9/1/2020] The U.S. Food and Drug Administration approved Sogroya (somapacitan) on August 28 for adults with growth hormone deficiency. Sogroya is the first human growth hormone (hGH) therapy that adult patients only take once a week by injection under the skin; other FDA-approved hGH formulations for adults with growth hormone deficiency must be administered daily.

Growth hormone deficiency is a disorder characterized by inadequate growth hormone production from the anterior pituitary gland, a small gland located at the base of the brain that produces several hormones. Adult patients with growth hormone deficiency can receive growth hormone as a replacement therapy.

Sogroya was evaluated in a randomized, double-blind, placebo-controlled trial in 300 patients with growth hormone deficiency who had never received growth hormone treatment or had stopped treatment with other growth hormone formulations at least three months before the study. Patients were randomly assigned to receive injections of weekly Sogroya, weekly placebo (inactive treatment), or daily somatropin, an FDA-approved growth hormone. The effectiveness of Sogroya was determined by the percentage change of truncal fat, the fat that is accumulated in the trunk or central area of the body that is regulated by growth hormone and can be associated with serious medical issues.

At the end of the 34-week treatment period, truncal fat decreased by 1.06%, on average, among patients taking weekly Sogroya while it increased among patients taking the placebo by 0.47%. In the daily somatropin group, truncal fat decreased by 2.23%. Patients in the weekly Sogroya and daily somatropin groups had similar improvements in other clinical endpoints.

The most common side effects of Sogroya include: back pain, joint paint, indigestion, a sleep disorder, dizziness, tonsillitis, swelling in the arms or lower legs, vomiting, adrenal insufficiency, hypertension, increase in blood creatine phosphokinase (a type of enzyme), weight increase, and anemia.

Sogroya should not be administered to patients with a history of hypersensitivity (allergy) to the drug. Sogroya should also not be used in patients with active malignancy, any stage of diabetic eye disease in which high blood sugar levels cause damage to blood vessels in the retina, acute critical illness, or those with acute respiratory failure, because of the increased risk of mortality with use of pharmacologic doses of Sogroya in critically ill patients without growth hormone deficiency.

Health care providers should perform an eye examination before starting Sogroya, and periodically thereafter, to exclude pre-existing papilledema (a condition in which there is swelling in the optic nerve at the back of the eye). Papilledema (swelling of the optic nerve) may be a symptom of intracranial hypertension (increased pressure inside the skull). Growth hormones may induce or worsen pre-existing intracranial hypertension.

FDA granted theapproval to Novo Nordisk, Inc.

09/01/2020

More:

FDA approves weekly therapy for adult growth hormone deficiency

A Comprehensive Study of the Human Growth Hormone Market: Opportunities and Challenges – EIN News

A Comprehensive Study of the Human Growth Hormone Market: Opportunities and Challenges  EIN News

View original post here:

A Comprehensive Study of the Human Growth Hormone Market: Opportunities and Challenges - EIN News

Everything to Know About Human Growth Hormone | Muscle & Fitness

The following list breaks down GH-boosting agents into seven categories: vitamins, minerals, amino acids, hormones, vital agents, herbs and botanicals, and adaptogenic herbs.

Many of the items listed heresuch as vitamins A, B5, B12, chromium, and zinccan be found in a daily multivitamin. Amino acids such as arginine, glutamine, and taurine are in many of our favorite pre- and post-workout supplements. Others, such as the hormone CHEA, the botanical extract chrysin, and the adaptogenic herb panaz ginseng, might not be part of the common products you already take but are sold separately.

Everything listed here is backed by years of research supporting its efficacy.

*Braverman says that real HGH is the only way to go if you truly have a deficiency, but added, Theres no question that when you take other hormonestestosterone, DHEA, estrogen, progesteronelots of people get growth hormone increases.

(Herbs with multiple, nonspecific actions that generally promote overall wellness)

Read the rest here:

Everything to Know About Human Growth Hormone | Muscle & Fitness

Growth Hormone Deficiency (GHD): Symptoms & Treatment – Cleveland Clinic

OverviewWhat is growth hormone deficiency (GHD)?

Growth hormone deficiency (GHD, or pituitary dwarfism) is a rare condition in which your pituitary gland doesnt release enough growth hormone (GH, or somatotropin). GHD can affect infants, children and adults. Children with GHD are shorter than expected with normal body proportions.

Hormones are chemicals that coordinate different functions in your body by carrying messages through your blood to your organs, muscles and other tissues. These signals tell your body what to do and when to do it.

Your pituitary gland is a small, pea-sized endocrine gland located at the base of your brain below your hypothalamus. Its made of two lobes: the anterior (front) lobe and posterior (back) lobe. Your anterior lobe makes GH. It releases eight hormones in total.

People with growth hormone deficiency may have hypopituitarism and have a deficiency in other pituitary hormones, including:

Growth hormone (GH) acts on many parts of the body to promote growth in children. Its essential for normal growth, muscle and bone strength and distribution of body fat.

Once the growth plates in your bones (epiphyses) have fused, GH no longer increases height, but your body still needs GH. After youve finished growing, GH helps to maintain normal body structure and metabolism, including helping to keep your blood glucose (sugar) levels within a healthy range.

If your body doesnt have enough growth hormone whether as an infant, child or adult it can greatly affect your body, albeit in different ways depending on your age. In infants and children, GHD prevents normal growth. In adults, it causes a variety of issues, including increased body fat and elevated blood sugar levels.

There are three main types of growth hormone deficiency (GHD), including:

Growth hormone deficiency is also categorized by the age of onset. It has different symptoms and processes for diagnosis if youre a child or adult when the condition begins.

Growth hormone deficiency (GHD) is a rare condition. About 1 in 4,000 to 10,000 children have GHD, and approximately 1 in every 10,000 people have adult-onset GHD.

The signs and symptoms of growth hormone deficiency (GHD) vary based on what age you are at the onset (start) of the condition.

Growth hormone deficiency (GHD) in infants and children results in poor growth. The main sign of GHD in children is slow height growth each year after a child's third birthday. This means they grow less than about 1.4 inches in height a year.

Other symptoms of GHD in children and infants include:

Symptoms of adult-onset GHD can be more difficult to detect. Symptoms include:

The causes of growth hormone deficiency (GHD) can vary based on what age you are at the onset (start) of the condition. Some cases of GHD are considered idiopathic, meaning the cause of the condition cant be determined.

Congenital growth hormone deficiency (GHD) results from a genetic mutation and may be associated with brain structure issues or with midline facial abnormalities, such as a cleft palate or single central incisor.

Scientists have identified several genetic mutations that cause GHD, including:

Isolated growth hormone deficiency can have different inheritance patterns depending on the type of the condition.

Cases of acquired growth hormone deficiency (GHD) result from damage to your pituitary gland that affects its ability to produce and release growth hormone. Children and adults can develop acquired GHD.

Pituitary damage can result from the following conditions or situations:

Diagnosis of growth hormone deficiency (GHD) in children most often occurs during two age ranges. The first is around 5 years of age when children begin school. This is because parents can more easily see how their childs height compares to the height of their classmates. The second age range is around 10 to 13 years old in children assigned female at birth and 12 to 16 years in children assigned male at birth, which are the age ranges when puberty typically starts. A delay in puberty can signal suspicion of GHD.

Growth increments are the most important criteria in the diagnosis of GHD in children. Normal levels of growth usually follow a pattern, and if growth during a recorded six- to twelve-month period is within those ranges, its unlikely that they have a growth condition.

Adult-onset growth hormone deficiency is often difficult to detect because the symptoms are subtle and commonplace. This makes it more difficult to diagnose.

Healthcare providers use different tests to diagnose growth hormone deficiency (GHD) depending on if youre a child or adult.

Your childs healthcare provider will review their medical history and growth charts to look for signs of impaired growth, risk factors for growth hormone deficiency and other conditions that can affect growth.

Other health conditions that can affect and prevent growth include:

Since growth hormone levels in your blood normally vary greatly throughout the day, a simple blood test cant determine a GH deficiency. Because of this, your childs provider may order the following tests to help diagnose GHD and/or to rule out other conditions that affect growth:

One of the most common tests for diagnosing growth hormone deficiency in adults is the insulin tolerance test. Insulin is a natural hormone your pancreas makes.

During this test, your provider will give you an injection of synthetic insulin to lower your blood sugar level. They will then take blood samples and send them to a lab for testing in order to measure the amount of growth hormone in your blood.

When your body experiences low blood sugar (hypoglycemia), it normally releases growth hormone. If your blood tests reveal lower-than-normal levels of growth hormone than whats expected for an insulin tolerance test, it confirms growth hormone deficiency.

Other tests may include:

Treatment for growth hormone deficiency (GHD) in both children and adults involves synthetic growth hormone (recombinant human growth hormone) injections (shots) given at home. People with GHD most often need a daily shot.

Synthetic growth hormone treatment is long-term, often lasting for several years. Its essential to see your healthcare provider regularly to make sure the treatment is working and to see if you need to adjust your dose of medication.

If you or your child have deficiencies in other pituitary hormones, you or they will also need treatment to correct those deficiencies.

Mild to moderate side effects of growth hormone injections for the treatment of growth hormone deficiency (GHD) are uncommon. They include:

Rare but serious side effects of GHD treatment include:

If youre experiencing any of these symptoms, its important to talk to your healthcare provider. They may need to adjust your medication dose.

Unfortunately, most cases of growth hormone deficiency (GHD) arent preventable. Certain risk factors can increase you or your childs likelihood of developing acquired GHD, including:

If any of these risk factors apply to you or your child, its important to talk to your healthcare provider about the signs and symptoms of GHD to look out for.

For children with growth hormone deficiency (GHD), the earlier the condition is treated, the better the chance that a child will grow to near-normal adult height. Many children gain four or more inches during the first year of treatment and three or more inches during the next two years of treatment. The rate of growth then slowly decreases.

People with adult-onset GHD generally have a good prognosis and can lead a healthy life if GHD is treated properly.

Left untreated, growth hormone deficiency in children may lead to short stature (height) and delayed puberty.

Despite proper treatment, people with adult-onset growth hormone deficiency have an increased risk of heart disease and stroke. Healthy living, such as eating a balanced diet and participating in routine exercise, can help reduce this risk.

People with adult-onset GHD also have a higher risk of developing osteoporosis. Because of this, they have a higher risk of developing bone fractures from minor injuries or falls. To decrease these risks, its important to have a diet thats rich in calcium and to take vitamin D supplements, as recommended by your healthcare provider.

There are many reasons for slow growth and below-average height in children. At times, slow growth is normal and temporary, such as right before puberty starts. If youre concerned about your childs rate of growth, see a pediatric endocrinologist (childrens hormone specialist) or healthcare provider. They can help find out if your childs rate of growth is cause for concern.

If youre an adult and are experiencing symptoms of growth hormone deficiency (GHD), talk to your healthcare provider.

If you or your child have been diagnosed with GHD, youll need to see your healthcare provider regularly to make sure your treatment is working properly.

A note from Cleveland Clinic

If youre noticing a lack of growth in your child, its important to talk to their healthcare provider as soon as possible. While it may be unlikely that growth hormone deficiency (GHD) is the cause, any concerning changes are worth evaluating. People with GHD who are diagnosed early have the best outlook and usually lead healthy lives. If you have any questions about what to expect with your childs growth, dont be afraid to reach out to their provider. Theyre there to help.

Go here to read the rest:

Growth Hormone Deficiency (GHD): Symptoms & Treatment - Cleveland Clinic

Acromegaly – Symptoms and causes – Mayo Clinic

Overview Illustration showing person with acromegaly Open pop-up dialog box

Close

Symptoms of acromegaly include an enlarged face and hands. Changes to the face may cause the brow bone and lower jawbone to protrude, and the nose and lips to get larger.

Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood.

When you have too much growth hormone, your bones increase in size. In childhood, this leads to increased height and is called gigantism. But in adulthood, a change in height doesn't occur. Instead, the increase in bone size is limited to the bones of your hands, feet and face, and is called acromegaly.

Because acromegaly is uncommon and the physical changes occur slowly over many years, the condition sometimes takes a long time to recognize. Untreated, high levels of growth hormone can affect other parts of the body, in addition to your bones. This can lead to serious sometimes even life-threatening health problems. But treatment can reduce your risk of complications and significantly improve your symptoms, including the enlargement of your features.

A common sign of acromegaly is enlarged hands and feet. For example, you may notice that you aren't able to put on rings that used to fit, and that your shoe size has progressively increased.

Acromegaly may also cause gradual changes in your face's shape, such as a protruding lower jaw and brow bone, an enlarged nose, thickened lips, and wider spacing between your teeth.

Because acromegaly tends to progress slowly, early signs may not be obvious for years. Sometimes, people notice the physical changes only by comparing old photos with newer ones.

Overall, acromegaly signs and symptoms tend to vary from one person to another, and may include any of the following:

If you have signs and symptoms associated with acromegaly, contact your doctor for an exam.

Acromegaly usually develops slowly. Even your family members may not notice the gradual physical changes that occur with this disorder at first. But early diagnosis is important so that you can start getting proper care. Acromegaly can lead to serious health problems if it's not treated.

Close

The pituitary gland and the hypothalamus are located within the brain and control hormone production.

Acromegaly occurs when the pituitary gland produces too much growth hormone (GH) over a long period of time.

The pituitary gland is a small gland at the base of your brain, behind the bridge of your nose. It produces GH and a number of other hormones. GH plays an important role in managing your physical growth.

When the pituitary gland releases GH into your bloodstream, it triggers your liver to produce a hormone called insulin-like growth factor-1 (IGF-1) sometimes also called insulin-like growth factor-I, or IGF-I. IGF-1 is what causes your bones and other tissues to grow. Too much GH leads to too much IGF-1, which can cause acromegaly signs, symptoms and complications.

In adults, a tumor is the most common cause of too much GH production:

If left untreated, acromegaly can lead to major health problems. Complications may include:

Early treatment of acromegaly can prevent these complications from developing or becoming worse. Untreated, acromegaly and its complications can lead to premature death.

Dec. 01, 2022

Read more here:

Acromegaly - Symptoms and causes - Mayo Clinic

Growth hormone-releasing hormone | You and Your Hormones from the …

Alternative names for growth hormone-releasing hormone

Growth hormone-releasing factor; GRF; GHRF; GHRH

Growth hormone-releasing hormone is a hormone produced in the hypothalamus.The main role of growth hormone-releasing hormone is to stimulate the pituitary gland to produce and release growth hormone into the bloodstream. This then acts on virtually every tissue of the body to control metabolism and growth. Growth hormone stimulates production of insulin-like growth factor 1in the liver and other organs, and this acts on tissues in the body to control metabolism and growth. In addition to its effect on growth hormone secretion, growth hormone-releasing hormone also affects sleep, food intake and memory.

The action of growth hormone-releasing hormone on the pituitary gland is counteracted by somatostatin, a hormone also produced by the hypothalamus, which prevents growth hormone release.

In order to maintain a normal balanced hormone production, growth hormone-releasing hormone, somatostatin, growth hormone and insulin-like growth factor 1 levels are regulated by each other.The consequence of growth hormone-releasing hormone action is an increase in the circulating levels of growth hormone and insulin-like growth factor 1 which, in turn, act back on the hypothalamus to prevent growth hormone-releasing hormone production and to stimulate somatostatin secretion.Somatostatin then prevents the release of growth hormone from the pituitary gland and growth hormone-releasing hormone production by the hypothalamus, therefore acting as a powerful suppressor of growth hormone secretion.

Many other factors and physiological conditions such as sleep, stress, exercise and food intake also affect the hypothalamic release of growth hormone-releasing hormone and somatostatin.

Too much growth hormone-releasing hormone production may be caused by hypothalamic tumours or by tumours located in other parts of the body (ectopic tumours). The consequence of too much growth hormone-releasing hormone is a rise in growth hormone levels in the bloodstream and, in many cases, enlargement of the pituitary gland.

In adults, excessive growth hormone for a long period of time produces a condition known as acromegaly in which patients have swelling of the hands and feet and altered facial features. These patients also have organ enlargement and serious functional disorders such as high blood pressure, diabetes and heart disease.An increase in growth hormone before children reach their final height can lead to excessive growth of long bones, resulting in the child being abnormally tall.This is commonly known as gigantism.

However, in most cases, growth hormone overproduction is caused by pituitary tumours that produce growth hormone; only in very rare occasions is excess growth hormone caused by overproduction of growth hormone-releasing hormone.

If the hypothalamus produces too little growth hormone-releasing hormone, the production and release of growth hormone from the pituitary gland is impaired, leading to a lack of growth hormone (adult-onset growth hormone deficiency).When a deficiency of growth hormone is suspected, a growth hormone stimulating test is performed using growth hormone-releasing hormone or other substances, in order to determine the ability of the pituitary gland to release growth hormone.

Childhood-onset growth hormone deficiency is associated with growth failure and delayed physical maturity. In adults, the most important consequences of reduced growth hormone levels are changes in body structure (decreased muscle and bone mass and increased body fat), tiredness, being less lively and a poor health-related quality of life.

Last reviewed: Feb 2018

See the original post:

Growth hormone-releasing hormone | You and Your Hormones from the ...

Growth Hormone Deficiency | Boston Children’s Hospital

How we diagnose growth hormone deficiency

The first step in treating your child is forming an accurate and complete diagnosis. Before a growth hormone deficiency diagnosis can be made, your child's physician may have to rule out other disorders first, including genetic short stature (inherited family shortness), inadequate caloric intake, thyroid hormone deficiency, and other illnesses, including gastrointestinal problems.

In addition to learning your child's complete medical history, gathering information about the heights and any health problems of your relatives, and conducting a physical examination, your child's doctor may:

Since growth hormone is produced in bursts, it is unlikely that any single blood sample will provide a definitive diagnosis.

If growth hormone deficiency is suspected, your physician may use a stimulant of growth hormone secretion (which may include vigorous exercise and/or several chemicals and medications), and measure the growth hormone release over time.

If growth hormone deficiency is diagnosed, your physician may order an MRI of the brain to look at the hypothalamus and pituitary gland.

After we complete all necessary tests, our experts meet to review and discuss what they have learned about your child's condition. Then we will meet with you and your family to discuss the results and outline the best treatment options.

Researchers are currently working on more efficient and accurate ways of diagnosing growth hormone deficiency.

Our physicians are focused on child-centered care, and we're known for our science-driven approach. Our experienced doctors know that growth hormone deficiencies are complex problems that can take different forms from patient to patient. Such an individualized illness may demand several thorough diagnostic tests and treatment specifically tailored to your child.

Typically, treatment of growth hormone deficiency involves receiving regular injections of synthetic human growth hormone, and children receive daily injections. Treatment usually lasts several years, although results are often seen as soon as three to four months after the injections are started.

The earlier treatment for growth hormone deficiency is started, the better chance the child will have of attaining her normal or near-normal adult height. However, not all children respond well to growth hormone treatment.

Children who have mutations that make their cells unresponsive to the growth hormone may be treated with injections of synthetic human IGF-1 instead.

The American Academy of Pediatrics (AAP) recommends that therapy with growth hormone is medically and ethically acceptable for children:

While there are many potential side effects, particularly if growth hormone is used to treat children who don't have a true hormone deficiency, researchers generally agree that treatment with human growth hormone is safe and effective. In 1985, the U.S. Food and Drug Administration (FDA) approved a biosynthetic growth hormone, thus:

Please consult your child's physician for more information.

Growth hormone deficiency may make your child feel insecure or self-conscious, and if appropriate, we can also put you in touch with mental health professionals to help with any negative feelings your child may be experiencing.

We understand that you may have a lot of questions when your child is diagnosed with growth hormone deficiency. How will it affect my child long-term? What do we do next? We've tried to provide some answers to those questions on this site, but there are also a number of other resources to guide you and your family through diagnosis and treatment.

Patient education: From the first office visit, our nurses will be on hand to walk you through your child's treatment and help answer any questions you may have What is treatment like? Are there any side effects? They will also reach out to you by phone, continuing the care and support you received while at Children's.

Parent to parent: Want to talk with someone whose child has been treated for growth hormone deficiency? We can often put you in touch with other families who can share their experience.

Social work: Our social workers and mental health clinicians have helped many other families in your situation. Your social worker can offer counseling and assistance with issues such as stresses relating to small stature, coping with your child's growth hormone deficiency diagnosis, and dealing with financial difficulties.

On our patient resources pages, you can read all you need to know about:

Read more from the original source:

Growth Hormone Deficiency | Boston Children's Hospital

Growth Hormone in Sport: What Athletes Should Know | USADA

When it comes to building speed, strength, and recovery, growth hormone (GH), and more specifically human growth hormone (hGH), has often been touted as one way to get an edge. Athletes, however, should know the risks associated with growth hormone from a health and clean sport perspective.

Humans naturally produce growth hormone, which controls how the body grows from childhood to adulthood but doesnt directly act on the bones and muscles. When growth hormone is released by the pituitary in the brain, it circulates in the blood and stimulates the release of a protein called IGF-1 from the liver. The IGF-1 protein is what ultimately stimulates the growth of bones, muscle, and other tissues.

Growth hormone levels are highest in children and decrease with age. While adults still produce growth hormone, the levels are much lower than in children and adolescents.

Yes. Growth hormone is in the category of Anabolic Agents on the World Anti-Doping Agency (WADA) Prohibited List and is prohibited at all times and for all levels of athletes, including elite, junior, and masters-level athletes. Even if you are prescribed growth hormone by a doctor for one of the conditions mentioned below, an approved Therapeutic Use Exemption (TUE) is required to use growth hormone in sport.

Growth hormone may only be legally prescribed for a small number of conditions. In pediatric patients, doctors can prescribe it to treat growth hormone deficiency, Prader-Willi syndrome, Turner syndrome, idiopathic short stature (when children are smaller than normal but there isnt a clear reason) and to treat growth failure in children born small who dont catch up by the time they are two.

In adults, growth hormone can also be prescribed to treat growth hormone deficiency as a result of pituitary disease, radiation therapy, or trauma. However, the medical use of growth hormone is complex because determining the right time to give the medication and figuring out who will actually benefit from it can be subjective. Growth hormone does not always cause a measurable increase in the rate of growth or development.

The use of growth hormone for an off-label use (not approved by the Food and Drug Administration) is unlawful and a felony under the Food, Drug, and Cosmetic Act. According to a statement by the Drug Enforcement Agency, growth hormone that is sold for wellness or anti-aging purposes is marketed, distributed, and illegally prescribed off-label to aging adults to replenish declining hGH levels and reverse age-related bodily deterioration.

Some wellness or anti-aging clinics also prescribe drugs that cause the body to release more growth hormone, such as growth hormone releasing hormone (GHRH) and other factors. Many compounds that are advertised to have these effects are investigational new drugs that are not yet approved by the FDA. Under the WADA Prohibited List, growth hormone releasing factors are prohibited at all times.

Athletes should check the anti-doping status of any medication they are prescribed on GlobalDRO.com before using them in sport.

Dietary supplements that claim to contain growth hormone or that advertise to cause the release of growth hormone should be avoided by athletes. The use of any dietary supplement is at the athletes own risk.

There are many reported side effects from the use of growth hormone, including irritation at the injection site, increased blood pressure in the brain, damage to the retina and vision in people with diabetes, damage to the growth plates in the femur in pediatric patients, faster progression of scoliosis in people who have this condition, hypothyroidism, pancreatitis, swelling or stiffness in the arms and legs, and generalized pain.

Long-term, the use of growth hormone may cause the body to stop producing its own, or to downregulate the growth hormone pathways.

For questions about specific products, substances, and methods, contact USADAs Drug Reference Line at drugreference@usada.org or call (719) 785-2000, option 2.

Excerpt from:

Growth Hormone in Sport: What Athletes Should Know | USADA

Cortisol – Wikipedia

Human natural glucocorticoid hormone

11,17,21-Trihydroxypregn-4-ene-3,20-dione

(1R,3aS,3bS,9aR,9bS,11aS)-1,10-Dihydroxy-1-(hydroxyacetyl)-9a,11a-dimethyl-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthen-7-one

InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1

Key:JYGXADMDTFJGBT-VWUMJDOOSA-N

O=C4C=C2/[C@]([C@H]1[C@@H](O)C[C@@]3([C@@](O)(C(=O)CO)CC[C@H]3[C@@H]1CC2)C)(C)CC4

Chemical compound

Cortisol is a steroid hormone, in the glucocorticoid class of hormones. When used as a medication, it is known as hydrocortisone.

It is produced in many animals, mainly by the zona fasciculata of the adrenal cortex in the adrenal gland.[1][bettersourceneeded] It is produced in other tissues in lower quantities.[2] It is released with a diurnal cycle and its release is increased in response to stress and low blood-glucose concentration. It functions to increase blood sugar through gluconeogenesis, to suppress the immune system, and to aid in the metabolism of fat, protein, and carbohydrates.[3] It also decreases bone formation.[4] Many of these functions are carried out by cortisol binding to glucocorticoid or mineralocorticoid receptors inside the cell, which then bind to DNA to impact gene expression.[5][6]

In general, cortisol stimulates gluconeogenesis (the synthesis of 'new' glucose from non-carbohydrate sources, which occurs mainly in the liver, but also in the kidneys and small intestine under certain circumstances). The net effect is an increase in the concentration of glucose in the blood, further complemented by a decrease in the sensitivity of peripheral tissue to insulin, thus preventing this tissue from taking the glucose from the blood. Cortisol has a permissive effect on the actions of hormones that increase glucose production, such as glucagon and adrenaline.[7]

Cortisol also plays an important, but indirect, role in liver and muscle glycogenolysis (the breaking down of glycogen to glucose-1-phosphate and glucose) which occurs as a result of the action of glucagon and adrenaline. Additionally, cortisol facilitates the activation of glycogen phosphorylase, which is necessary for adrenaline to have an effect on glycogenolysis.[8][9]

Paradoxically, cortisol promotes not only gluconeogenesis in the liver, but also glycogenesis. Cortisol is thus better thought of as stimulating glucose/glycogen turnover in the liver.[10] This is in contrast to cortisol's effect in the skeletal muscle where glycogenolysis is promoted indirectly through catecholamines.[11]

Elevated levels of cortisol, if prolonged, can lead to proteolysis (breakdown of proteins) and muscle wasting.[12] The reason for proteolysis is to provide the relevant tissue with a feedstock for gluconeogenesis; see glucogenic amino acids.[7] The effects of cortisol on lipid metabolism are more complicated since lipogenesis is observed in patients with chronic, raised circulating glucocorticoid (i.e. cortisol) levels,[7] although an acute increase in circulating cortisol promotes lipolysis.[13] The usual explanation to account for this apparent discrepancy is that the raised blood glucose concentration (through the action of cortisol) will stimulate insulin release. Insulin stimulates lipogenesis, so this is an indirect consequence of the raised cortisol concentration in the blood but it will only occur over a longer time scale.

Cortisol prevents the release of substances in the body that cause inflammation. It is used to treat conditions resulting from overactivity of the B-cell-mediated antibody response. Examples include inflammatory and rheumatoid diseases, as well as allergies. Low-dose topical hydrocortisone, available as a nonprescription medicine in some countries, is used to treat skin problems such as rashes and eczema.

Cortisol inhibits production of interleukin 12 (IL-12), interferon gamma (IFN-gamma), IFN-alpha, and tumor necrosis factor alpha (TNF-alpha) by antigen-presenting cells (APCs) and T helper cells (Th1 cells), but upregulates interleukin 4, interleukin 10, and interleukin 13 by Th2 cells. This results in a shift toward a Th2 immune response rather than general immunosuppression. The activation of the stress system (and resulting increase in cortisol and Th2 shift) seen during an infection is believed to be a protective mechanism which prevents an over-activation of the inflammatory response.[14]

Cortisol can weaken the activity of the immune system. It prevents proliferation of T-cells by rendering the interleukin-2 producer T-cells unresponsive to interleukin-1, and unable to produce the T-cell growth factor IL-2. Cortisol downregulates the expression of the IL2 receptor IL-2R on the surface of the helper T-cell which is necessary to induce a Th1 'cellular' immune response, thus favoring a shift towards Th2 dominance and the release of the cytokines listed above which results in Th2 dominance and favors the 'humoral' B-cell mediated antibody immune response).[15]

Cortisol also has a negative-feedback effect on IL-1.[16]The way this negative feedback works is that an immune stressor causes peripheral immune cells to release IL-1 and other other cytokines such as IL-6 and TNF-alpha. These cytokines stimulate the hypothalamus, causing it to release corticotropin-releasing hormone (CRH). CRH in turn stimulates the production of adrenocorticotropic hormone (ACTH) among other things in the adrenal gland, which (among other things) increases production of cortisol. Cortisol then closes the loop as it inhibits TNF-alpha production in immune cells and makes them less responsive to IL-1.[17]

Through this system, as long as an immune stressor is small, the response will be regulated to the correct level. Like a thermostat controlling a heater, the hypothalamus uses cortisol to turn off the heat once the production of cortisol matches the stress induced on the immune system. But in a severe infection or in a situation where the immune system is overly sensitized to an antigen (such as in allergic reactions) or there is a massive flood of antigens (as can happen with endotoxic bacteria) the correct set point might never be reached. Also because of downregulation of Th1 immunity by cortisol and other signaling molecules, certain types of infection, (notably Mycobacterium tuberculosis) can trick the body into getting locked in the wrong mode of attack, using an antibody-mediated humoral response when a cellular response is needed.

Lymphocytes are the antibody-producing cells of the body, and are thus the main agents of humoral immunity. A larger number of lymphocytes in the lymph nodes, bone marrow, and skin means the body is increasing its humoral immune response. Lymphocytes release antibodies into the bloodstream. These antibodies lower infection through three main pathways: neutralization, opsonization, and complement activation. Antibodies neutralize pathogens by binding to surface adhering proteins, keeping pathogens from binding to host cells. In opsonization, antibodies bind to the pathogen and create a target for phagocytic immune cells to find and latch onto, allowing them to destroy the pathogen more easily. Finally antibodies can also activate complement molecules which can combine in various ways to promote opsonization or even act directly to lyse a bacteria. There are many different kinds of antibody and their production is highly complex, involving several types of lymphocyte, but in general lymphocytes and other antibody regulating and producing cells will migrate to the lymph nodes to aid in the release of these antibodies into the bloodstream.[18]

Rapid administration of corticosterone (the endogenous type I and type II receptor agonist) or RU28362 (a specific type II receptor agonist) to adrenalectomized animals induced changes in leukocyte distribution.

On the other side of things, there are natural killer cells; these cells are equipped with the heavy artillery needed to take down larger in size threats like bacteria, parasites, and tumor cells. A separate study[19] found that cortisol effectively disarmed natural killer cells, downregulating the expression of their natural cytotoxicity receptors. Interestingly, prolactin has the opposite effect. It increases the expression of cytotoxicity receptors on natural killer cells, increasing their firepower.

Cortisol stimulates many copper enzymes (often to 50% of their total potential), including lysyl oxidase, an enzyme that cross-links collagen and elastin. Especially valuable for immune response is cortisol's stimulation of the superoxide dismutase,[20] since this copper enzyme is almost certainly used by the body to permit superoxides to poison bacteria.

Cortisol counteracts insulin, contributes to hyperglycemia by stimulating gluconeogenesis[21] and inhibits the peripheral use of glucose (insulin resistance)[21][bettersourceneeded] by decreasing the translocation of glucose transporters (especially GLUT4) to the cell membrane.[22] Cortisol also increases glycogen synthesis (glycogenesis) in the liver, storing glucose in easily accessible form.[23] The permissive effect of cortisol on insulin action in liver glycogenesis is observed in hepatocyte culture in the laboratory, although the mechanism for this is unknown.

Cortisol reduces bone formation,[4] favoring long-term development of osteoporosis (progressive bone disease). The mechanism behind this is two-fold: cortisol stimulates the production of RANKL by osteoblasts which stimulates, through binding to RANK receptors, the activity of osteoclasts cells responsible for calcium resorption from bone and also inhibits the production of osteoprotegerin (OPG) which acts as a decoy receptor and captures some RANKL before it can activate the osteoclasts through RANK.[7] In other words, when RANKL binds to OPG, no response occurs as opposed to the binding to RANK which leads to the activation of osteoclasts.

It transports potassium out of cells in exchange for an equal number of sodium ions (see above).[24] This can trigger the hyperkalemia of metabolic shock from surgery. Cortisol also reduces calcium absorption in the intestine.[25] Cortisol down-regulates the synthesis of collagen.[26]

Cortisol raises the free amino acids in the serum by inhibiting collagen formation, decreasing amino acid uptake by muscle, and inhibiting protein synthesis.[27] Cortisol (as opticortinol) may inversely inhibit IgA precursor cells in the intestines of calves.[28] Cortisol also inhibits IgA in serum, as it does IgM; however, it is not shown to inhibit IgE.[29]

Cortisol decreases glomerular filtration rate,[medical citation needed] and renal plasma flow from the kidneys thus increasing phosphate excretion,[medical citation needed] as well as increasing sodium and water retention and potassium excretion by acting on mineralocorticoid receptors. It also increases sodium and water absorption and potassium excretion in the intestines.[30]

Cortisol promotes sodium absorption through the small intestine of mammals.[31] Sodium depletion, however, does not affect cortisol levels[32] so cortisol cannot be used to regulate serum sodium. Cortisol's original purpose may have been sodium transport. This hypothesis is supported by the fact that freshwater fish use cortisol to stimulate sodium inward, while saltwater fish have a cortisol-based system for expelling excess sodium.[33]

A sodium load augments the intense potassium excretion by cortisol. Corticosterone is comparable to cortisol in this case.[34] For potassium to move out of the cell, cortisol moves an equal number of sodium ions into the cell.[24] This should make pH regulation much easier (unlike the normal potassium-deficiency situation, in which two sodium ions move in for each three potassium ions that move outcloser to the deoxycorticosterone effect).

Cortisol stimulates gastric-acid secretion.[35] Cortisol's only direct effect on the hydrogen-ion excretion of the kidneys is to stimulate the excretion of ammonium ions by deactivating the renal glutaminase enzyme.[36]

Cortisol works with adrenaline (epinephrine) to create memories of short-term emotional events; this is the proposed mechanism for storage of flash bulb memories, and may originate as a means to remember what to avoid in the future.[37] However, long-term exposure to cortisol damages cells in the hippocampus;[38] this damage results in impaired learning.

Diurnal cycles of cortisol levels are found in humans.[8]

Sustained stress can lead to high levels of circulating cortisol (regarded as one of the more important of the several "stress hormones").[39]

During human pregnancy, increased fetal production of cortisol between weeks 30 and 32 initiates production of fetal lung pulmonary surfactant to promote maturation of the lungs. In fetal lambs, glucocorticoids (principally cortisol) increase after about day 130, with lung surfactant increasing greatly, in response, by about day 135,[40] and although lamb fetal cortisol is mostly of maternal origin during the first 122 days, 88% or more is of fetal origin by day 136 of gestation.[41] Although the timing of fetal cortisol concentration elevation in sheep may vary somewhat, it averages about 11.8 days before the onset of labor.[42] In several livestock species (e.g. cattle, sheep, goats, and pigs), the surge of fetal cortisol late in gestation triggers the onset of parturition by removing the progesterone block of cervical dilation and myometrial contraction. The mechanisms yielding this effect on progesterone differ among species. In the sheep, where progesterone sufficient for maintaining pregnancy is produced by the placenta after about day 70 of gestation,[43][44] the prepartum fetal cortisol surge induces placental enzymatic conversion of progesterone to estrogen. (The elevated level of estrogen stimulates prostaglandin secretion and oxytocin receptor development.)

Exposure of fetuses to cortisol during gestation can have a variety of developmental outcomes, including alterations in prenatal and postnatal growth patterns. In marmosets, a species of New World primates, pregnant females have varying levels of cortisol during gestation, both within and between females. Infants born to mothers with high gestational cortisol during the first trimester of pregnancy had lower rates of growth in body mass indices than infants born to mothers with low gestational cortisol (about 20% lower). However, postnatal growth rates in these high-cortisol infants were more rapid than low-cortisol infants later in postnatal periods, and complete catch-up in growth had occurred by 540 days of age. These results suggest that gestational exposure to cortisol in fetuses has important potential fetal programming effects on both pre and postnatal growth in primates.[45]

Cortisol is produced in the human body by the adrenal gland in the zona fasciculata,[1] the second of three layers comprising the adrenal cortex. The cortex forms the outer "bark" of each adrenal gland, situated atop the kidneys. The release of cortisol is controlled by the hypothalamus, a part of the brain. The secretion of corticotropin-releasing hormone by the hypothalamus[46] triggers cells in the neighboring anterior pituitary to secrete another hormone, the adrenocorticotropic hormone (ACTH), into the vascular system, through which blood carries it to the adrenal cortex. ACTH stimulates the synthesis of cortisol and other glucocorticoids, mineralocorticoid aldosterone, and dehydroepiandrosterone.[47]

Normal values indicated in the following tables pertain to humans (normal levels vary among species). Measured cortisol levels, and therefore reference ranges, depend on the sample type (blood or urine), analytical method used, and factors such as age and sex. Test results should, therefore, always be interpreted using the reference range from the laboratory that produced the result.[medical citation needed]

Using the molecular weight of 362.460g/mole, the conversion factor from g/dL to nmol/L is approximately 27.6; thus, 10g/dL is about 276 nmol/L.[medical citation needed]

Cortisol follows a circadian rhythm, and to accurately measure cortisol levels is best to test four times per day through saliva. An individual may have normal total cortisol but have a lower than normal level during a certain period of the day and a higher than normal level during a different period. Therefore, some scholars question the clinical utility of cortisol measurement.[54][55][56][57]

Cortisol is lipophilic, and is transported bound to transcortin (also known as corticosteroid-binding globulin) and albumin, while only a small part of the total serum cortisol is unbound and has biological activity.[58] This binding to the corticosteroid-binding globulin is accomplished through hydrophobic interactions in which cortisol binds in a 1:1 ratio.[59] Serum cortisol assays measures total cortisol, and its results may be misleading for patients with altered serum protein concentrations. The salivary cortisol test avoids this problem because only free cortisol can pass through the salivary barrier.[medical citation needed] Transcortin particles are too large to pass through this barrier.[medical citation needed]

Automated immunoassays lack specificity and show significant cross-reactivity due to interactions with structural analogs of cortisol, and show differences between assays. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can improve specificity and sensitivity.[60]

Some medical disorders are related to abnormal cortisol production, such as:

The primary control of cortisol is the pituitary gland peptide, ACTH, which probably controls cortisol by controlling the movement of calcium into the cortisol-secreting target cells.[64] ACTH is in turn controlled by the hypothalamic peptide corticotropin-releasing hormone (CRH), which is under nervous control. CRH acts synergistically with arginine vasopressin, angiotensin II, and epinephrine.[65] (In swine, which do not produce arginine vasopressin, lysine vasopressin acts synergistically with CRH.[66])

When activated macrophages start to secrete IL-1, which synergistically with CRH increases ACTH,[16] T-cells also secrete glucosteroid response modifying factor (GRMF), as well as IL-1; both increase the amount of cortisol required to inhibit almost all the immune cells.[67] Immune cells then assume their own regulation, but at a higher cortisol setpoint. The increase in cortisol in diarrheic calves is minimal over healthy calves, however, and falls over time.[68] The cells do not lose all their fight-or-flight override because of interleukin-1's synergism with CRH. Cortisol even has a negative feedback effect on interleukin-1[16]especially useful to treat diseases that force the hypothalamus to secrete too much CRH, such as those caused by endotoxic bacteria. The suppressor immune cells are not affected by GRMF,[67] so the immune cells' effective setpoint may be even higher than the setpoint for physiological processes. GRMF affects primarily the liver (rather than the kidneys) for some physiological processes.[69]

High-potassium media (which stimulates aldosterone secretion in vitro) also stimulate cortisol secretion from the fasciculata zone of canine adrenals[70][71] unlike corticosterone, upon which potassium has no effect.[72]

Potassium loading also increases ACTH and cortisol in humans.[73] This is probably the reason why potassium deficiency causes cortisol to decline (as mentioned) and causes a decrease in conversion of 11-deoxycortisol to cortisol.[74] This may also have a role in rheumatoid-arthritis pain; cell potassium is always low in RA.[75]

Ascorbic acid presence, particularly in high doses has also been shown to mediate response to psychological stress and speed the decrease of the levels of circulating cortisol in the body post-stress. This can be evidenced through a decrease in systolic and diastolic blood pressures and decreased salivary cortisol levels after treatment with ascorbic acid.[76]

Cortisol is synthesized from cholesterol. Synthesis takes place in the zona fasciculata of the adrenal cortex. (The name cortisol is derived from cortex.) While the adrenal cortex also produces aldosterone (in the zona glomerulosa) and some sex hormones (in the zona reticularis), cortisol is its main secretion in humans and several other species. (However, in cattle, corticosterone levels may approach[84] or exceed[8] cortisol levels.). The medulla of the adrenal gland lies under the cortex, mainly secreting the catecholamines adrenaline (epinephrine) and noradrenaline (norepinephrine) under sympathetic stimulation.

The synthesis of cortisol in the adrenal gland is stimulated by the anterior lobe of the pituitary gland with ACTH; ACTH production is, in turn, stimulated by CRH, which is released by the hypothalamus. ACTH increases the concentration of cholesterol in the inner mitochondrial membrane, via regulation of the steroidogenic acute regulatory protein. It also stimulates the main rate-limiting step in cortisol synthesis, in which cholesterol is converted to pregnenolone and catalyzed by Cytochrome P450SCC (side-chain cleavage enzyme).[85]

Cortisol is metabolized reversibly to cortisone[86] by the 11-beta hydroxysteroid dehydrogenase system (11-beta HSD), which consists of two enzymes: 11-beta HSD1 and 11-beta HSD2. The metabolism of cortisol to cortisone involves oxidation of the hydroxyl group at the 11-beta position.[87]

Overall, the net effect is that 11-beta HSD1 serves to increase the local concentrations of biologically active cortisol in a given tissue; 11-beta HSD2 serves to decrease local concentrations of biologically active cortisol. If hexose-6-phosphate dehydrogenase (H6PDH) is present, the equilibrium can favor the activity of 11-beta HSD1. H6PDH regenerates NADPH, which increases the activity of 11-beta HSD1, and decreases the activity of 11-beta HSD2.[88]

An alteration in 11-beta HSD1 has been suggested to play a role in the pathogenesis of obesity, hypertension, and insulin resistance known as metabolic syndrome.[89]

An alteration in 11-beta HSD2 has been implicated in essential hypertension and is known to lead to the syndrome of apparent mineralocorticoid excess (SAME).

Cortisol is also metabolized irreversibly into 5-alpha tetrahydrocortisol (5-alpha THF) and 5-beta tetrahydrocortisol (5-beta THF), reactions for which 5-alpha reductase and 5-beta-reductase are the rate-limiting factors, respectively. 5-Beta reductase is also the rate-limiting factor in the conversion of cortisone to tetrahydrocortisone.

Cortisol is also metabolized irreversibly into 6-hydroxycortisol by cytochrome p450-3A monooxygenases, mainly, CYP3A4.[90][91][86][92] Drugs that induce CYP3A4 may accelerate cortisol clearance.[93]

Cortisol is a naturally occurring pregnane corticosteroid and is also known as 11,17,21-trihydroxypregn-4-ene-3,20-dione.

In animals, cortisol is often used as an indicator of stress and can be measured in blood,[94] saliva,[94] urine,[95] hair,[96] and faeces.[96][97]

See the original post:

Cortisol - Wikipedia

Growth Hormone Deficiency | Endocrine Society

espaol >

Growth hormone deficiency (GHD) is a rare condition in which the body does not make enough growth hormone (GH). Human growth hormone (GH) is a substance that controls childrens growth. Among children with short stature, GHD happens in approximately 1:4,000 to 1:10,000 cases.

GH is made by the pituitary gland, a small organ at the base of the brain. In children, GH is essential for normal growth, muscle and bone strength, and distribution of body fat. It also helps control glucose (sugar) and lipid (fat) levels in the body. Without enough GH, a child is likely to grow slowly and be much shorter than other children of the same age and gender.

GH works through a growth factor called insulin-like growth factor 1 (IGF-1). GH stimulates the liver to produce IGF-1 and release it into the circulation. IGF-1 then works at multiple tissues, like bone and cartilage, to promote growth. In addition, GH produces IGF-1 locally at tissues such as bone and cartilage.

Some children are born with GHD (congenital), while others develop it after birth (acquired).Children with congenital GHD may lack additional hormones produced by the pituitary gland.Some children with congenital GHD are found to have mutations (errors in the genes) that involve the development of the pituitary gland or GH production and action.In certain instances, congenital GH deficiency also can be seen as part of a syndrome that may affect the development of the middle of the face.

GHD may develop during childhood or adulthood (acquired GHD) after any process that can damage the pituitary gland or the surrounding brain area. Causes of acquired GHD include brain tumor, surgery, severe brain injury, or radiation of the area that is usually given for treatment of cancer. Rarely, acquired GHD can be the result of a chronic inflammation of the pituitary called hypophysitis, a condition that can be seen after treatment with certain cancer medications. In all these cases, the individual may have additional deficiencies of other pituitary hormones.

Most children with childhood-onset GHD have no additional hormone deficiencies, and doctors cannot find any cause for GHD. These cases of acquired GHD are also called isolated or idiopathic and are not inherited.For some children, slow growth is not caused by GHD.There are many reasons for slow growth and below-average height in children. At times, slow growth is normal and temporary, such as right before puberty starts. A pediatric endocrinologist (childrens hormone specialist) or primary care doctor can help find out why a child is growing slowly. Most children with GHD grow less than two inches (5 centimeters) each year.

The single most important clinical sign of GHD in children is growth failure. Children with GHD have severe short stature with normal proportions and appropriate body weight. Review of their growth chart usually shows a drop in height across two or more percentiles.

Your doctor will review your childs medical history and growth charts and look for signs of GHD and other conditions that affect growth. Your doctor may do tests to help find the cause of slow growth. These include:

X-Ray: An X-ray of the hand and wrist, called bone ageto assess growth potential in children.

Blood Tests: A doctor may order a blood test to rule out other conditions that affect growth.

IGF-1 levels: Additional blood work testing for levels of growth factors, such as Insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3), are helpful in diagnosing GHD.

GH stimulation test: During this test, the child is given medicines that stimulate the pituitary to release GH. If GH levels in the blood dont rise to a certain level, it can mean that the pituitary is not making enough GH.

Magnetic resonance image (MRI): An MRI (imaging test) of the head is usually done in individuals with GHD to look for a problem with the pituitary or the brain.

If IGF1 levels are low in the blood test, it may indicate that the person may have GHD. However, there are additional causes of low IGF1 levels, such as liver disease or low body weight.

Common symptoms that are present with a diagnosis of growth hormone deficiency include:

Babies with severe congenital GHD usually have only a slightly reduced birth length and may not immediately show signs of slow growth. In these children, a low blood sugar can be the main sign of GHD.

Adults with severe GHD may also experience:

Irradiation, surgery or injury to the pituitary area of the brain can increase the chance of developing acquired GHD. Untreated children with GHD reach a short adult height. Untreated GHD in adults may increase risk for heart disease and fractures.

People with GHD receive treatment with daily injections of synthetic (manufactured) human GH, a prescription medicine. GH is given at home as an injection under the skin at bedtime. More recently, a sustained release GH that is given as a weekly injection under the skin has become available.

Individuals treated with GH need regular doctor check-ups. In children, your doctor usually monitors the growth response to GH and changes in IGF1 levels in the blood and bone age x ray.

GH therapy is effective in improving growth and results in a normal adult height. The best results occur when GHD is diagnosed and treated early. In some children, GH can lead to four inches (10 centimeters) of growth during the first year of treatment. Therapy can continue until the child completes his/her growth and reaches adult height. At that point, the individual can be re-tested to see if he/she should continue GH therapy as an adult. Most of the childhood-onset cases of isolated GHD do not need therapy in adult life.In children, mild to moderate side effects are uncommon. They include:

Rare but serious side effects include:

For most children, the benefits of taking GH outweigh the risks.In adults, the GH side effects are also rare and can be swelling of hands and feet, joint pains and carpal tunnel syndrome. An increase risk for type II diabetes can happen in people with certain genetic predisposition such as Prader Will syndrome.

Concerns have been raised about a possibility that GH may increase an individuals cancer risk. Several studies so far point out that GH treatment for individuals with GHD does not increase the risk for leukemia or other cancers compared with age-matched healthy people.

You can help your child get the best care for GHD by taking these steps:

Endocrine Library >>

Editor(s): Alan Rogol, M.D., Henry Anhalt, DO, Melanie Schorr Haines, M.D., Maria George Vogiatzi, M.D.

Last Updated: January 24, 2022

Read more from the original source:

Growth Hormone Deficiency | Endocrine Society